Immunosuppressive Agents: all 5,940 studies that test it
Page 52 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMDStatus unknownNCT00370539Phase 3
- Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMDStatus unknownNCT00370370Phase 3
- A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular EdemaCompletedNCT00369863Phase 2
- Sirolimus in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00368914Phase 1
- Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic DermatitisCompletedNCT00367393Phase 4
- Treatment of Newly Diagnosed Elderly Patients With Multiple MyelomaCompletedNCT00367185Phase 3
- A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.CompletedNCT00365001Phase 1
- A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant RecipientsCompletedNCT00363116Phase 4
- A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's DiseaseWithdrawnNCT00358683Phase 3
- Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma PatientsCompletedNCT00358020Phase 2
- Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell TransplantCompletedNCT00357084Phase 2
- Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic MalignanciesTerminatedNCT00356928Phase 1
- 16.0040 Ankylosing Spondylitis StudyCompletedNCT00356356Phase 3
- Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular CarcinomaCompletedNCT00355862Phase 3
- Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood TransplantTerminatedNCT00354419Phase 1
- Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural MesotheliomaCompletedNCT00354393Phase 2
- Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining FistulasWithdrawnNCT00354367Phase 3
- S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00352443Phase 1
- Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast CancerCompletedNCT00352378Phase 3
- Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic DermatitisCompletedNCT00351052Phase 3
- WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated VasculitidesStatus unknownNCT00349674Phase 3
- TCD Followed by autoSCT for Newly Diagnosed MM PatientsStatus unknownNCT00349115Phase 2
- Efficacy of Topical Cyclosporin for Ocular RosaceaCompletedNCT00348335Phase 4
- Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis PatientsCompletedNCT00347048Phase 3
- Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT00346918Phase 3
- Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid CancerCompletedNCT00346359Phase 2
- An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid ArthritisCompletedNCT00346294Phase 4
- A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving MethotrexateCompletedNCT00345748Phase 2
- Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in AdultsTerminatedNCT00344942Phase 3
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesCompletedNCT00343798Phase 1
- Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic LeukemiaWithdrawnNCT00343447Phase 2
- An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.CompletedNCT00343226Phase 4
- EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in ChildrenStatus unknownNCT00339118Phase 4
- Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic MelanomaActive, not recruitingNCT00338377Phase 2
- Phase II Trial of RAD001 in Refractory Colorectal CancerCompletedNCT00337545Phase 2
- Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.CompletedNCT00337493Phase 4
- A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid CancersTerminatedNCT00337376Phase 1
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaCompletedNCT00337246Phase 2
- Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With PsoriasisCompletedNCT00333034Phase 3
- Etanercept in Hidradenitis SuppurativaCompletedNCT00329823Phase 2
- Combination Daclizumab/Denileukin Diftitox to Treat UveitisCompletedNCT00326508Phase 2
- Pharmacokinetic Study on the Combination of Everolimus-TacrolimusStatus unknownNCT00325325Phase 2
- Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic MelanomaCompletedNCT00324623Phase 1
- CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell LymphomasCompletedNCT00323323Phase 1
- Treatment of Oral Erosive Lichen Planus With Pimecrolimus CreamTerminatedNCT00321750Phase 2
- Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal GraftsCompletedNCT00321074Phase 3
- A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA PatientsCompletedNCT00319917Phase 4
- Sirolimus and Cyclosporine for Treatment-Resistant Aplastic AnemiaStatus unknownNCT00319878Phase 1/2
- PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple MyelomaStatus unknownNCT00319865Phase 2
- Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's AnemiaCompletedNCT00317876Phase 1
- Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple MyelomaCompletedNCT00317798Phase 1
- Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other DiseasesCompletedNCT00317785Phase 2
- Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV MelanomaCompletedNCT00317759Phase 1
- Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)CompletedNCT00317681Phase 2
- Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to EtanerceptCompletedNCT00317538Phase 3
- Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and PsoriasisCompletedNCT00317499Phase 3
- Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.CompletedNCT00314977Phase 3
- Use of Thalidomide in Chronic UveitisTerminatedNCT00314665Phase 4
- Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple MyelomaCompletedNCT00313625Phase 2
- Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHLCompletedNCT00311129Phase 2
- AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast CancerCompletedNCT00310089Not applicable
- Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative PatientsCompletedNCT00309569Phase 3
- Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive PatientsCompletedNCT00309478Phase 3
- Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular EdemaCompletedNCT00309192Phase 3
- An Open Study for Steroid Resistant, Non-Thymectomized MG PatientsCompletedNCT00309101Phase 3
- FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) PatientsCompletedNCT00309088Phase 3
- Treatment of Necrotizing Vasculitides for Patients Older Than 65 YearsCompletedNCT00307671Phase 4
- IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic VasculitisTerminatedNCT00307645Phase 3
- Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis VulgarisCompletedNCT00306878Phase 1
- Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant RecipientsCompletedNCT00306397Phase 4
- Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First RemissionCompletedNCT00305708Phase 1/2
- SARCOTHAL. Thalidomide in Skin SarcoidosisCompletedNCT00305552Phase 3
- Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney TransplantationCompletedNCT00305396Phase 4
- Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family DonorStatus unknownNCT00304720Phase 2
- Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00304018Phase 1
- Vatalanib and Everolimus in Treating Patients With Advanced Solid TumorsCompletedNCT00303732Phase 1
- To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LNCompletedNCT00302549Not applicable
- Tacrolimus Treatment of Patients With Idiopathic Focal Segmental GlomerulosclerosisWithdrawnNCT00302536Not applicable
- Tacrolimus Treatment of Patients With Idiopathic Membranous NephropathyCompletedNCT00302523Not applicable
- EXTEND Protocol for Transplanted Patient to Evaluate Kidney FunctionStatus unknownNCT00302497Phase 3
- Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00301951Phase 1
- Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryStatus unknownNCT00301925Phase 3
- Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWithdrawnNCT00301912Phase 2
- Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic PainTerminatedNCT00301405Phase 2
- Combination Therapy of Betaseron-Prograf in Multiple SclerosisStatus unknownNCT00298662Phase 2
- Methotrexate in the Treatment of Axial SpondyloarthritisWithdrawnNCT00298012Phase 4
- Optimizing Prograf® Therapy in Renal Transplant PatientsCompletedNCT00297765Phase 4
- Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney TransplantationCompletedNCT00297310Phase 4
- To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.CompletedNCT00296361Phase 3
- Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney TransplantationCompletedNCT00296348Phase 3
- Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.CompletedNCT00296309Phase 3
- Phase II High-Dose Cyclophosphamide for Multiple SclerosisWithdrawnNCT00296205Phase 2
- Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerCompletedNCT00296023Not applicable
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency DiseaseCompletedNCT00295971Phase 1
- Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant PatientsCompletedNCT00295607Phase 2
- Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.CompletedNCT00295594Phase 3
- A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293930Phase 3
- A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293917Phase 3
- A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293891Phase 3
- Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System LymphomaStatus unknownNCT00293475Phase 1/2